Letter in response to the recently published review: hyponatremia in cirrhosis and end-stage liver disease--treatment with the vasopressin v2-receptor antagonist tolvaptan.
作者信息
Abhyankar A, Robson S C, Tapper E B, Bonder A
出版信息
Dig Dis Sci. 2013 Mar;58(3):889-90. doi: 10.1007/s10620-013-2573-5. Epub 2013 Jan 31.
PMID:23371016
Abstract
摘要
Zotero 插件